Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia
Authors:
- 9 January 2009
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 16 (6) , 508-515
Abstract
Cell surface presence of the coxsackie and adenovirus receptor (CAR) is considered a crucial prerequisite for the uptake of attenuated adenovirus. In cancers, however, a frequent loss of CAR has been noted potentially hampering the success of adenovirus-based therapy. In esophageal Barrett's carcinomas and its precursor lesions CAR presence has not been systematically determined yet. Immunohistochemical assessment in tissue specimens of 111 patients revealed CAR-positivity in all cases of Barrett's esophagus, including various degrees of intraepithelial neoplasia. In contrast, no considerable CAR presence was seen in squamous esophageal epithelium. Among Barrett's carcinomas, 93% displayed CAR presence, whereas CAR-negativity was observed preferentially in advanced cancers. Aiming to evaluate whether this loss of CAR impacts tumor-biologic properties of esophageal adenocarcinomas we studied cell lines OE19 and OE33 and observed an increased proliferation, migration and invasion upon siRNA-mediated functional CAR knock down. In conclusion, our results indicate that CAR may provide a valuable target for adenovirus-based therapy of Barrett's carcinomas and its precursor lesions. These data do also suggest that CAR does not contribute substantially to carcinogenesis in Barrett's esophagus, however, it may be speculated that loss of CAR promotes tumor progression in advanced stages of Barrett's carcinomas.Keywords
This publication has 26 references indexed in Scilit:
- Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s EsophagusGastroenterology, 2007
- The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasisExperimental Cell Research, 2006
- Coxsackie and Adenovirus Receptor Promotes Adenocarcinoma Cell Survival and Is Expressionally Activated after Transition from Preneoplastic Precursor Lesions to Invasive AdenocarcinomasClinical Cancer Research, 2005
- Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal modelsCancer Gene Therapy, 2005
- Barrett’s oesophagus: from metaplasia to dysplasia and cancerGut, 2005
- Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3Current Medical Science, 2005
- Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: Requirement for the C‐terminal domainInternational Journal of Cancer, 2004
- The coxsackie adenovirus receptor inhibits cancer cell migrationExperimental Cell Research, 2004
- Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivoCancer Gene Therapy, 2004
- Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsCancer Gene Therapy, 2001